CRNX - Company ID 0001658247
The table below shows Crinetics Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $101.54M | $264.55M | $54.90M | $32.67M | $200.69M | $93.09M |
| Short-term investments | $926.35M | $1.09B | $503.66M | $301.75M | $133.01M | $77.79M |
| Receivables | $592.00K | - | - | - | - | - |
| Inventory | $2.02M | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.05B |
| $1.38B |
| $574.15M |
| $345.18M |
| $344.72M |
| $177.49M |
| Property, plant & equipment | $14.30M | $12.07M | $10.88M | $3.50M | $2.83M | $3.18M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.13B | $1.43B | $635.35M | $352.18M | $351.01M | $183.44M |
| Accounts payable | $22.61M | $5.85M | $6.55M | $6.88M | - | - |
| Total current liabilities | $85.07M | $59.68M | $43.94M | $27.72M | $15.99M | $10.49M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $134.17M | $109.79M | $96.25M | $35.85M | $19.07M | $14.53M |
| Retained earnings | -$1.42B | -$952.11M | -$653.70M | -$439.17M | -$275.25M | -$167.61M |
| Total equity | $992.08M | $1.32B | $539.11M | $316.33M | $331.94M | $168.92M |